Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company has a market capitalization of $8.1 billion and operates through Protein Sciences, Diagnostics and Spatial Biology segments.

Companies with a market cap between $2 billion and $10 billion are typically referred to as “mid-cap stocks.” Bio-Techne sits comfortably there, with its market cap exceeding this threshold, reflecting its scale, dominance, and market power.

Fundamentals

See More
  • Market Capitalization, $K 8,054,201
  • Shares Outstanding, K 156,453
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 117 M
  • EBITDA $ 227 M
  • 60-Month Beta 1.48
  • Price/Sales 6.62
  • Price/Cash Flow 21.10
  • Price/Book 4.01

Options Overview Details

View History
  • Implied Volatility 54.76% (+0.06%)
  • Historical Volatility 41.66%
  • IV Percentile 84%
  • IV Rank 51.93%
  • IV High 71.44% on 04/07/25
  • IV Low 36.75% on 09/16/25
  • Expected Move (DTE 24) 4.63 (8.91%)
  • Put/Call Vol Ratio 0.45
  • Today's Volume 16
  • Volume Avg (30-Day) 1,997
  • Put/Call OI Ratio 1.98
  • Today's Open Interest 33,610
  • Open Int (30-Day) 25,514
  • Expected Range 47.37 to 56.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.48
  • Number of Estimates 6
  • High Estimate 0.51
  • Low Estimate 0.40
  • Prior Year 0.50
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.25 +7.77%
on 03/16/26
59.06 -11.95%
on 02/27/26
-2.76 (-5.04%)
since 02/23/26
3-Month
48.25 +7.77%
on 03/16/26
72.16 -27.94%
on 01/22/26
-7.25 (-12.24%)
since 12/23/25
52-Week
46.01 +13.02%
on 04/21/25
72.16 -27.94%
on 01/22/26
-8.61 (-14.21%)
since 03/21/25

Most Recent Stories

More News
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks

Bio-Techne has underperformed other biotechnology stocks over the past year, yet analysts remain moderately optimistic about the stock’s growth potential.

TECH : 52.00 (+1.01%)
BBIO : 69.60 (+1.55%)
XBI : 121.70 (+1.16%)
3 Cash-Producing Stocks with Open Questions

3 Cash-Producing Stocks with Open Questions

TECH : 52.00 (+1.01%)
KHC : 21.21 (-1.67%)
HIMX : 8.68 (+1.05%)
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know

TECH : 52.00 (+1.01%)
STE : 221.00 (+0.44%)
TFX : 105.85 (+0.42%)
BRKR : 34.86 (+4.53%)
DXCM : 65.94 (-1.51%)
3 Reasons to Avoid TECH and 1 Stock to Buy Instead

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

TECH : 52.00 (+1.01%)
3 Small-Cap Stocks We Keep Off Our Radar

3 Small-Cap Stocks We Keep Off Our Radar

TECH : 52.00 (+1.01%)
ITGR : 85.33 (+1.46%)
INGM : 21.93 (-0.90%)
Bio-Techne to Present at Upcoming Investor Conferences

MINNEAPOLIS , Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TECH : 52.00 (+1.01%)
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know

MEDP : 456.93 (+0.98%)
TECH : 52.00 (+1.01%)
OSCR : 12.21 (-3.33%)
AZTA : 20.45 (+1.29%)
RVTY : 87.16 (+1.42%)
1 Profitable Stock to Target This Week and 2 We Avoid

1 Profitable Stock to Target This Week and 2 We Avoid

TECH : 52.00 (+1.01%)
FAST : 44.45 (+1.58%)
ELV : 289.24 (-0.77%)
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge‑Based Immunoassays for European Clinical Laboratories

MINNEAPOLIS  , Feb. 16, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced that the Ella benchtop...

TECH : 52.00 (+1.01%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

AAON : 80.29 (+0.35%)
TECH : 52.00 (+1.01%)
VLTO : 88.50 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 55.04
2nd Resistance Point 54.29
1st Resistance Point 53.14
Last Price 52.00
1st Support Level 51.24
2nd Support Level 50.49
3rd Support Level 49.34

See More

52-Week High 72.16
Fibonacci 61.8% 62.17
Fibonacci 50% 59.08
Fibonacci 38.2% 56.00
Last Price 52.00
52-Week Low 46.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.